Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate Tablet
Product Images NDC 64980-104

1 FDA label image from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate (NDC 64980-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Phospha 250-container-label (Phospha 250 Container Label)

Phospha 250-container-label (Phospha 250 Container Label)
Phopha 250 Neutral 250 mg tablets carton from Rising Pharmaceuticals. The label indicates phosphorus supplement tablets supplying 250 mg per tablet, with a count of 100 tablets. The label includes ingredient and usage information, NDC 64980-104-01, and states Rx only. Barcode and manufacturer details are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.